Suchergebnisse - "Scott Montgomery"

Author reply

Autoren: Karin Hilden David Simmons Ulf Hanson et al.

Quelle: BJOG: An International Journal of Obstetrics & Gynaecology. 131:1433-1433

Schlagwörter: Gynaecology, Obstetrics and Reproductive Medicine, Gynekologi, obstetrik och reproduktionsmedicin

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38472158
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-544997

Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence—authors' reply

Autoren: Isabella Visuri Carl Eriksson Ola Olén et al.

Quelle: Alimentary Pharmacology & Therapeutics. 54:848-849

Schlagwörter: 03 medical and health sciences, 0302 clinical medicine, Crohn Disease, Adalimumab, Antibodies, Monoclonal, Humans, Tumor Necrosis Factor Inhibitors, Infliximab

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.16569
https://pubmed.ncbi.nlm.nih.gov/34425010
https://onlinelibrary.wiley.com/doi/10.1111/apt.16569

Letter: vedolizumab or a second anti‐TNF—no difference in efficacy for primary biologic failures with IBD. Authors' reply

Autoren: Sara Rundquist Carl Eriksson Ola Olén et al.

Quelle: Alimentary Pharmacology & Therapeutics. 53:1046-1047

Schlagwörter: Sweden, 03 medical and health sciences, Biological Products, 0302 clinical medicine, Pharmaceutical Preparations, Tumor Necrosis Factor-alpha, Humans, Antibodies, Monoclonal, Humanized, Inflammatory Bowel Diseases, 3. Good health

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33831234
https://europepmc.org/article/MED/33831234
https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16352
https://onlinelibrary.wiley.com/doi/10.1111/apt.16352
https://pubmed.ncbi.nlm.nih.gov/33831234/
https://www.ncbi.nlm.nih.gov/pubmed/33831234

Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors’ reply

Autoren: Scott Montgomery Carl Eriksson Sara Rundquist et al.

Quelle: Alimentary Pharmacology & Therapeutics. 53:642-643

Schlagwörter: Sweden, Pharmaceutical Preparations, Tumor Necrosis Factor-alpha, Humans, Antibodies, Monoclonal, Humanized, Inflammatory Bowel Diseases

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33566420
https://europepmc.org/article/MED/33566420
https://pubmed.ncbi.nlm.nih.gov/33566420/
https://onlinelibrary.wiley.com/doi/10.1111/apt.16241
http://www.ncbi.nlm.nih.gov/pubmed/33566420
https://www.ncbi.nlm.nih.gov/pubmed/33566420

Editorial: do thiopurines and biologics decrease the risk of colectomy? Authors’ reply

Autoren: Carl Eriksson Yaroslava Zhulina Ida Henriksson et al.

Quelle: Alimentary Pharmacology & Therapeutics. 46:897-898

Schlagwörter: Risk, 0301 basic medicine, Biological Products, 03 medical and health sciences, 0302 clinical medicine, Humans, Colitis, Ulcerative, Colectomy

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14336
https://pubmed.ncbi.nlm.nih.gov/29023888
https://onlinelibrary.wiley.com/doi/full/10.1111/apt.14336
http://onlinelibrary.wiley.com/doi/10.1111/apt.14336/full
https://www.ncbi.nlm.nih.gov/pubmed/29023888
https://europepmc.org/article/MED/29023888
https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.14336
http://www.diva-portal.org/smash/record.jsf?pid=diva2:1152312

Letter: complications of coeliac disease despite a gluten‐free diet – authors' reply

Autoren: Jonas F. Ludvigsson Anders Ekbom Alberto Rubio-Tapia et al.

Quelle: Alimentary Pharmacology & Therapeutics. 37:762-763

Schlagwörter: Male, 0301 basic medicine, Celiac Disease, 03 medical and health sciences, 0302 clinical medicine, Intestine, Small, Humans, Female, Intestinal Mucosa, 3. Good health

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.12243
https://pubmed.ncbi.nlm.nih.gov/23458542
https://www.ncbi.nlm.nih.gov/pubmed/23458542
https://mayoclinic.pure.elsevier.com/en/publications/letter-complications-of-coeliac-disease-despite-a-gluten-free-die
http://www.diva-portal.org/smash/record.jsf?pid=diva2:614861
http://europepmc.org/abstract/MED/23458542

Letter: persisting clinical symptoms in microscopic colitis in remission - authors′ reply

Autoren: Scott Montgomery Curt Tysk Nils Nyhlin et al.

Quelle: Alimentary Pharmacology & Therapeutics. 40:118-118

Schlagwörter: Colitis, Lymphocytic, Male, 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Colitis, Collagenous, Quality of Life, Humans, Female

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/24903433
http://www.diva-portal.org/smash/record.jsf?pid=diva2:741273
https://www.ncbi.nlm.nih.gov/pubmed/24903433

Author Index.

Quelle: Pharmacoepidemiology & Drug Safety; Nov2024 Supplement 1, Vol. 33, p1-37, 37p

Author reply.

Autoren: Hilden, Karin Simmons, David Hanson, Ulf et al.

Quelle: BJOG: An International Journal of Obstetrics & Gynaecology; Sep2024, Vol. 131 Issue 10, p1433-1433, 1p

Schlagwörter: GESTATIONAL diabetes, TYPE 1 diabetes, TYPE 2 diabetes, CARDIOVASCULAR diseases, PREECLAMPSIA

Intensive Care management of Hemophagocytic Lymphohistiocytosis: a case series.

Autoren: Traversi, Riccardo Arrigo, Gabriele Bonetto, Chiara et al.

Quelle: BMC Anesthesiology; 11/14/2025, Vol. 25 Issue 1, p1-7, 7p

Schlagwörter: BIOPSY, INTRAVENOUS immunoglobulins, ADRENOCORTICAL hormones, HEMOPHAGOCYTIC lymphohistiocytosis, PATIENTS, FERRITIN, KILLER cells, AUTOPSY, HOSPITAL admission & discharge, MULTIPLE organ failure, PROBABILITY theory, TREATMENT effectiveness, RETROSPECTIVE studies, HEMODIALYSIS, ETOPOSIDE, INTENSIVE care units, MEDICAL records, ACQUISITION of data, FIBRINOGEN, TRIGLYCERIDES, METHYLPREDNISOLONE, CRITICAL care medicine, DEXAMETHASONE, SYMPTOMS

Comparison of Complication and Readmission Rates Between Robot-Assisted and Open Radical Cystectomy: Results From the Randomized RAZOR Clinical Trial.

Autoren: Venkatramani, Vivek Reis, Isildinha M. Gonzalgo, Mark L. et al.

Quelle: Journal of Urology; Jun2025, Vol. 213 Issue 6, p684-692, 9p

Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence—authors' reply.

Autoren: Visuri, Isabella Eriksson, Carl Olén, Ola et al.

Quelle: Alimentary Pharmacology & Therapeutics; Sep2021, Vol. 54 Issue 6, p848-849, 2p

Schlagwörter: INFLIXIMAB, ADALIMUMAB, EVIDENCE, AUTHORS, TUMOR necrosis factors

Global cross-sectional survey on neonatal pharmacologic sedation and analgesia practices and pain assessment tools: impact of the sociodemographic index (SDI).

Autoren: Arribas, Cristina Cavallaro, Giacomo Gonzalez, Juan-Luis et al.

Quelle: Pediatric Research; Sep2024, Vol. 96 Issue 4, p964-975, 12p

Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: A stepped wedge cluster randomised trial.

Autoren: de Brun, Maryam Magnuson, Anders Montgomery, Scott et al.

Quelle: PLoS Medicine; 7/8/2024, Vol. 21 Issue 7, p1-23, 23p

Schlagwörter: GASTRIC bypass, GESTATIONAL diabetes, FETAL surgery, PREGNANCY outcomes, GLUCOSE tolerance tests, BLOOD sugar, BIRTH weight

Geografische Kategorien: SWEDEN

Firma/Körperschaft: WORLD Health Organization

Contemporary Authors: A Bio-Bibliographical Guide to Current Writers in Fiction, General Non-Fiction, Poetry, Journalism, Drama, Motion Pictures, Television, & Other Fields

Autoren: Gale Research Inc

Resource Type: eBook.

Categories: BIOGRAPHY & AUTOBIOGRAPHY / Literary Figures, REFERENCE / Bibliographies & Indexes

Contemporary Authors: A Bio-Bibliographical Guide to Current Writers in Fiction, General Non-Fiction, Poetry, Journalism, Drama, Motion Pictures, Television, & Other Fields

Autoren: Mary Ruby

Resource Type: eBook.

Categories: BIOGRAPHY & AUTOBIOGRAPHY / Literary Figures, REFERENCE / Bibliographies & Indexes

Letter: vedolizumab or a second anti‐TNF—no difference in efficacy for primary biologic failures with IBD. Authors' reply.

Autoren: Rundquist, Sara Sachs, Michael C Eriksson, Carl et al.

Quelle: Alimentary Pharmacology & Therapeutics; May2021, Vol. 53 Issue 9, p1046-1047, 2p

Schlagwörter: VEDOLIZUMAB, AUTHORS, INFLAMMATORY bowel diseases

Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors' reply.

Autoren: Rundquist, Sara Sachs, Michael C. Eriksson, Carl et al.

Quelle: Alimentary Pharmacology & Therapeutics; Mar2021, Vol. 53 Issue 5, p642-643, 2p

Schlagwörter: VEDOLIZUMAB, SURPRISE, GAMES, AUTHORS, THERAPEUTICS

Comorbid allergy and rhinitis and patient-related outcomes in asthma and COPD: a cross-sectional study.

Autoren: Al-Hadrawi, Zainab Giezeman, Maaike Hasselgren, Mikael et al.

Quelle: European Clinical Respiratory Journal; Dec2024, Vol. 11 Issue 1, p1-7, 7p

Disproportionately raised risk of adverse outcomes in patients with COPD and comorbid type 2 diabetes or depression: Swedish register-based cohort study.

Autoren: Smith, Carolina Hasselgren, Mikael Sandelowsky, Hanna et al.

Quelle: Respiratory Research; 3/5/2025, Vol. 26 Issue 1, p1-9, 9p

Schlagwörter: CHRONIC obstructive pulmonary disease, TYPE 2 diabetes, COHORT analysis, CARDIOVASCULAR diseases, ODDS ratio, COMORBIDITY, MENTAL depression, MORTALITY